Daniel Mikol
Chief Tech/Sci/R&D Officer chez NERVGEN PHARMA CORP.
Fortune : - $ au 31/03/2024
Profil
Dr. Daniel Mikol is a Chief Medical Officer at NervGen Pharma Corp.
Dr. Mikol was previously employed as an Executive Medical Director by Amgen, Inc. and an Associate Professor by University of Michigan.
He received his doctorate degree from The University of Chicago.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NERVGEN PHARMA CORP.
-.--% | 19/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Daniel Mikol
| Sociétés | Poste | Début |
|---|---|---|
| NERVGEN PHARMA CORP. | Chief Tech/Sci/R&D Officer | 05/05/2021 |
Anciens postes connus de Daniel Mikol
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/05/2021 |
| University of Michigan | Corporate Officer/Principal | - |
Formation de Daniel Mikol
| The University of Chicago | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| NERVGEN PHARMA CORP. | Health Technology |
